Products

^PrBOTOX^® is indicated for the prophylaxis of headaches in adults with chronic migraine (≥15 days per month with headache lasting 4 hours a day or longer).

Please consult the Product Monograph at: abbv.ie/BotoxCanadaPMEN for contraindications, serious warnings and precautions, other warnings and precautions, adverse reactions, interactions, dosing and conditions of clinical use. The Product Monograph is also available by calling: 1-888-704-8271.

^PrQULIPTA^® is indicated for the prevention of episodic migraine (<15 migraine days per month) in adults.

Please consult the Product Monograph at: https://www.abbvie.ca/content/dam/abbvie-dotcom/ca/en/documents/products/QULIPTA_PM_EN.pdf for contraindications, serious warnings and precautions, other warnings and precautions, adverse reactions, interactions, dosing and conditions of clinical use. The Product Monograph is also available by calling: 1-888-704-8271.

Please consult the Product Monograph at: https://www.abbvie.ca/content/dam/abbvie-dotcom/ca/en/documents/products/UBRELVY_PM_EN.pdf for contraindications, warnings, precautions, adverse reactions, interactions, dosing and conditions of clinical use. The Product Monograph is also available by calling: 1-888-704-8271.